Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DIFLUNISAL vs DIFLUPREDNATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DIFLUNISAL vs DIFLUPREDNATE: Safety Overview

Metric DIFLUNISAL DIFLUPREDNATE
Total FAERS Reports 101 1,681
Deaths Reported 13 5
Death Rate 12.9% 0.3%
Hospitalizations 24 60
Average Patient Age 67.2 yrs 61.2 yrs
% Female Patients 72.3% 62.8%
FDA Approval Date Apr 19, 1982 Aug 9, 2021
Manufacturer Zydus Pharmaceuticals (USA) Inc. Amneal Pharmaceuticals NY LLC
Route ORAL OPHTHALMIC
Marketing Status Discontinued Prescription